News

Multimedia

Conferences

Publications

Brand Insights

Resources

Sustainability
DE&I
Pandemic
Finance
Legal
Technology
Regulatory
Global
Pricing
Strategy
R&D/Clinical Trials
Opinion
Executive Roundtable
Sales & Marketing
Executive Profiles
Leadership
Market Access
Patient Engagement
Supply Chain
Industry Trends

Florida's Nephron to Cut 250 Jobs

January 22, 2016

Article

January 22, 2016.

Nephron Pharmaceuticals is to cut 250 jobs at its Orlando, FL manufacturing facility, according to the Orlando Business Journal.â¨â¨ In October 2015, Nephron filed a WARN notice stating that 400 employees - almost its entire Orlando workforce - would be laid off between Jan. 1-15. But CEO Lou Kennedy later confirmed that only 180 of the 450 employees received layoff notices. Nephron is shifting operations to South Carolina on account of the state's attractive tax incentives.

Related Content

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver

November 19th 2024

Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan

November 15th 2024

Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle

November 14th 2024

Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.